<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>Amoxicillin-Clavulanate - Medications - Offline Clinical Reference</title>
  <link rel="stylesheet" href="../style.css">
</head>
<body>
  <div class="topbar">
    <div class="topbar-inner">
      <span class="pill"><strong>Amoxicillin-Clavulanate</strong></span>
      <span class="spacer"></span>
      <div class="nav-btns">
        <a class="btn small" href="../../index.html">Home</a>
        <a class="btn small" href="../../index.html#/sickbay-meds">Back to Medications</a>
      </div>
    </div>
  </div>

  <main class="wrap">
    <section class="section">
      <div class="kicker">Antibiotics / Antivirals</div>
      <h1>Amoxicillin-Clavulanate</h1>

      <div class="content">
        <h3>Stocked on board</h3>
        <ul>
          <li>Amoxicillin-Clavulanate 500mg Tablets</li>
        </ul>

        <div class="rule"></div>

        <h3>Adult dosing</h3>
        <p><strong>Note:</strong> Dosing expressed as amoxicillin component. Common onboard formulation: 500 mg amoxicillin / 125 mg clavulanate tablets.</p>
        <ul>
          <li><strong>Acute bacterial sinusitis (when antibiotics indicated and broader coverage needed)</strong>
            <ul>
              <li>500 mg (amoxicillin component) PO every 8 hours OR 875 mg (if available) PO every 12 hours for 5–7 days</li>
              <li>If using 500 mg tablets onboard: 500 mg PO every 8 hours</li>
            </ul>
          </li>
          <li><strong>Community-acquired pneumonia (when broader coverage needed vs amoxicillin alone)</strong>
            <ul>
              <li>500 mg PO every 8 hours OR 875 mg (if available) PO every 12 hours for 5–7 days</li>
            </ul>
          </li>
          <li><strong>Skin and soft tissue infections (e.g., cellulitis, infected wounds; when beta-lactamase-producing organisms suspected)</strong>
            <ul>
              <li>500 mg PO every 8 hours OR 875 mg (if available) PO every 12 hours for 5–10 days depending on severity</li>
            </ul>
          </li>
          <li><strong>Animal/human bites (prophylaxis or early infection)</strong>
            <ul>
              <li>500 mg PO every 8 hours OR 875 mg (if available) PO every 12 hours for 3–5 days (prophylaxis) or 5–7 days (established infection)</li>
            </ul>
          </li>
          <li><strong>Dental infections (odontogenic infections)</strong>
            <ul>
              <li>500 mg PO every 8 hours for 5–7 days</li>
            </ul>
          </li>
          <li><strong>Renal dosing adjustments</strong>
            <ul>
              <li>Dose adjustment required in significant renal impairment; follow product monograph/medical direction</li>
            </ul>
          </li>
        </ul>

        <div class="rule"></div>

        <h3>Indications</h3>
        <ul>
          <li>Bacterial infections caused by beta-lactamase-producing organisms resistant to amoxicillin alone</li>
          <li>Clavulanate is a beta-lactamase inhibitor that extends amoxicillin spectrum to include many Staph aureus, H. influenzae, Moraxella, anaerobes, and other resistant organisms</li>
          <li>Acute bacterial sinusitis, community-acquired pneumonia, skin/soft tissue infections, bite wounds, dental infections (when broader coverage vs amoxicillin alone is indicated)</li>
        </ul>

        <div class="rule"></div>

        <h3>Contraindications / cautions</h3>
        <ul>
          <li>History of immediate hypersensitivity to penicillins (and caution with cephalosporin cross-reactivity depending on reaction)</li>
          <li>History of amoxicillin-clavulanate-associated cholestatic jaundice or hepatic dysfunction</li>
          <li>Suspected/confirmed infectious mononucleosis (rash risk with aminopenicillins)</li>
          <li>Dose adjustment required in significant renal impairment</li>
          <li>C. difficile-associated diarrhea risk: reassess if significant diarrhea develops during/after therapy</li>
          <li>GI upset (nausea, diarrhea) more common than with amoxicillin alone due to clavulanate component</li>
          <li>Hepatotoxicity (rare but serious): monitor for signs of liver dysfunction; risk increases with treatment &gt;14 days or repeated courses</li>
          <li>Interactions: INR may increase with warfarin (monitor if applicable)</li>
        </ul>

        <div class="rule"></div>

        <h3>Adverse effects</h3>
        <ul>
          <li>GI upset (nausea, diarrhea, abdominal discomfort) – more common than amoxicillin alone</li>
          <li>Rash, urticaria</li>
          <li>Hypersensitivity reactions (urticaria → anaphylaxis)</li>
          <li>C. difficile-associated diarrhea (important but uncommon)</li>
          <li>Hepatotoxicity (rare; cholestatic jaundice, hepatitis—usually reversible upon discontinuation)</li>
          <li>Headache, dizziness (uncommon)</li>
        </ul>

        <div class="rule"></div>

        <h3>Preparation &amp; administration</h3>
        <ul>
          <li>Take at the start of a meal to enhance absorption and reduce GI upset</li>
          <li>Take at evenly spaced intervals (every 8 or 12 hours depending on formulation)</li>
          <li>Counsel: finish the prescribed course unless told otherwise; do not share leftover antibiotics</li>
          <li>If significant diarrhea develops, reassess for C. difficile; if mild GI upset, taking with food may improve tolerance</li>
          <li>Do NOT substitute tablets with different amoxicillin:clavulanate ratios (different formulations are not interchangeable mg-for-mg)</li>
        </ul>

        <div class="rule"></div>

        <h3>Monitoring</h3>
        <ul>
          <li>Clinical response within 48–72 hours (symptoms, fever, function)</li>
          <li>Allergy/rash; stop and seek help if signs of anaphylaxis</li>
          <li>GI tolerability and diarrhea severity (consider C. difficile if severe/persistent)</li>
          <li>If prolonged course (&gt;14 days) or high-risk patient: monitor liver function and renal function when feasible</li>
          <li>If on warfarin: monitor INR more closely</li>
        </ul>

        <div class="rule"></div>

        <h3>At-sea considerations</h3>
        <ul>
          <li>Broader spectrum than amoxicillin alone; use when beta-lactamase-producing organisms suspected (e.g., MSSA, resistant H. influenzae) or for specific indications (bite wounds, dental infections)</li>
          <li>Antibiotic stewardship: reserve for appropriate indications; use amoxicillin alone when sufficient to avoid unnecessary broad-spectrum exposure</li>
          <li>GI upset more common—counsel patient and encourage taking with food; ensure adequate hydration</li>
          <li>If diagnostics are limited, reassess early non-response and consider alternate diagnosis or need for escalation/evac</li>
          <li>Document start date, dose, planned duration, allergy status, and indication clearly</li>
        </ul>

        <div class="rule"></div>

        <h3>Online-only references</h3>
        <ul>
          <li>Health Canada product monograph (amoxicillin-clavulanate – Clavulin): <a href="https://pdf.hres.ca/dpd_pm/00067671.PDF" target="_blank" rel="noopener">https://pdf.hres.ca/dpd_pm/00067671.PDF</a></li>
          <li>Health Canada product monograph (amoxicillin-clavulanate – Apo-Amoxi-Clav): <a href="https://pdf.hres.ca/dpd_pm/00058816.PDF" target="_blank" rel="noopener">https://pdf.hres.ca/dpd_pm/00058816.PDF</a></li>
          <li>RxFiles (Acute Sinusitis antibiotic summary – Canadian): <a href="https://rxfiles.ca/rxfiles/uploads/documents/ABX-Sinusitis.pdf" target="_blank" rel="noopener">https://rxfiles.ca/rxfiles/uploads/documents/ABX-Sinusitis.pdf</a></li>
        </ul>
      </div>

      <p class="foot">
        Verify dosing and indications against current clinical guidelines.
      </p>
    </section>
  </main>
</body>
</html>
